Abstract:Clinical studies have found 14-3-3η to be associated with osteoporosis through undefined mechanisms. We aimed to investigate the role of 14-3-3η in osteoporosis and its potential associations with miRNAs. The Gene Expression Omnibus(GEO) and Human Protein Atlas 1 databases were analyzed to examine both the mRNA and protein expression of 14-3-3η in OP. Gene enrichment analyses were performed to explore the underlying mechanism of 14-3-3η based on DAVID. miRWalk was used to predict the associated miRNAs. The statistics were analysed by R software and SPSS software. 14-3-3η was overexpressed and knock down expressed in BMSCs by lentiviral vector transfecting. And BMSCs were induced by hypoxia. qRT-PCR and Western-Blot verified the expression of mRNA and protein. Scratch assay detected the migration of osteocytes. Co-immunoprecipitation and luciferase assay studied the 14-3-3η targeted protein and miRNA. overexpression and knock down of miRNA to verify the relationship of 14-3-3η and target genes. The 14-3-3η mRNA expression level was low in patients with osteoporosis, as corroborated by immunohistochemical staining images. Functional analyses revealed enrichment of the MAPK-associated cascade. 14-3-3η was correlated with MAPK family proteins and five key miRNAs, including mir-142-3p. In addition, 14-3-3η knockdown in BMSCs increased the mRNA and protein expression levels of Hif-α, VEGF, BMP-2, OPN, OST, and Runx2, and enhanced the cells migration ability. Under hypoxic conditions, Hif-α and BMP-2 protein expression levels were upregulated, whereas those of 14-3-3η and MAPK3 were downregulated. Co-immunoprecipitation experiments showed decreased binding of 14-3-3η to MAPK3. 14-3-3η knockdown produced the same results as hypoxia induction. Adding caspase3 inhibitor and knocking down 14-3-3η again prevented MAPK3 cleavage by caspase3 and inhibited BMP-2 expression. Moreover, under hypoxic conditions, miR-142-3P expression was upregulated and luciferase assays revealed 14-3-3η as its target gene. miR-142-3P overexpression decreased mRNA and protein levels of 14-3-3η and MAPK3, while increasing BMP-2 expression. miR-142-3P knockdown reversed these results. BMSC osteogenesis was suppressed by 14-3-3η , whereas miRNA-142-3p promoted it through the inhibition of 14-3-3η .

Mir‑483‑3p Promotes the Osteogenesis of Human Osteoblasts Bytargeting Dikkopf 2 (DKK2) and the Wnt Signaling Pathway

miR‐483‐3p promotes the osteogenesis of human osteoblasts by�targeting Dikkopf 2 (DKK2) and the Wnt signaling pathway

Biological Role of miRNA-302a-3p/DKK1 in Osteogenesis of Bone-Marrow Derived Mesenchymal Stem Cells

MiR-486–3p promotes osteogenic differentiation of BMSC by targeting CTNNBIP1 and activating the Wnt/β-catenin pathway

MiR-486-3p promotes osteogenic differentiation of BMSCs by targeting CTNNBIP1 and activating Wnt/β-catenin pathway

Mir-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration Via Repressing Dkk3

Mir-664-3p Suppresses Osteoblast Differentiation And Impairs Bone Formation Via Targeting Smad4 And Osterix

MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10

MiR-9 promotes osteoblast differentiation of mesenchymal stem cells by inhibiting DKK1 gene expression

Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis

Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‐derived mesenchymal stem cells by regulating DKK1 via targeting miR‐103a‐3p

MicroRNA-483-5p inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells by targeting the RPL31-mediated RAS/ MEK/ERK signaling pathway

MicroRNA-497-5p stimulates osteoblast differentiation through HMGA2-mediated JNK signaling pathway

Osteoblast-targeted Delivery of Mir-33-5p Attenuates Osteopenia Development Induced by Mechanical Unloading in Mice.

miR-18a-5p promotes osteogenic differentiation of BMSC by inhibiting Notch2

Elevation of Mir-302B Prevents Multiple Myeloma Cell Growth and Bone Destruction by Blocking DKK1 Secretion

miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway

Mmu-miR-185 Depletion Promotes Osteogenic Differentiation and Suppresses Bone Loss in Osteoporosis Through the Bgn-mediated BMP/Smad Pathway

Circulating Micrornas, Mir-10B-5p, Mir-328-3p, Mir-100 and Let-7, Are Associated with Osteoblast Differentiation in Osteoporosis.

Mir-532-3p Inhibits Osteogenic Differentiation in MC3T3-E1 Cells by Downregulating ETS1.

MicroRNA-877-5p promotes osteoblast differentiation by targeting EIF4G2 expression